We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Lifts Clinical Hold on CytRx’s ALS Drug
FDA Lifts Clinical Hold on CytRx’s ALS Drug
December 4, 2009
CytRx may resume clinical trials of its oral drug arimoclomol to treat amyotrophic lateral sclerosis (ALS) because the FDA has accepted its revision of
a study protocol.